MannKind Corp. (MNKD) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
"main_header": {
"sid": 1157257,
"name": "MannKind Corp.",
"stock_name": "MannKind Corp.",
"full_name": "MannKind Corp.",
"name_url": "stocks-analysis/mannkind-corp",
"exchange": 210,
"exchangecode": "NAS",
"country_id": 2,
"currency": "USD",
"cmp": "5.71",
"chg": 0.12,
"chgp": "2.15%",
"dir": 1,
"prev_price": "5.59",
"mcapval": "1,709.03",
"mcap": "Small Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2305,
"indexname": "S&P 500",
"isin": "US56400P7069",
"curr_date": "Dec 04",
"curr_time": "",
"bse_nse_vol": "4.72 M",
"exc_status": "Active",
"traded_date": "Dec 04, 2025",
"traded_date_str": "2025 12 04",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-register-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mannkind-corp-1157257-210&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "MannKind Corp. Hits Day High with Strong 10.58% Intraday Surge",
"link": "https://www.marketsmojo.com/news/stocks-in-action/mannkind-corp-hits-day-high-with-strong-1058-intraday-surge-3676129",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MannKindCorp_priceRelatedfactors_3676129.png",
"date": "2025-11-06 16:14:10",
"description": "MannKind Corp. has seen a notable increase in its stock performance today, reaching an intraday high amid broader market trends. Despite recent gains, the company faces long-term challenges, including a decline in one-year performance and negative financial indicators, highlighting a complex market position."
},
{
"title": "MannKind Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics",
"link": "https://www.marketsmojo.com/news/stocks-in-action/mannkind-corps-technical-trend-changes-from-bullish-to-mildly-bullish-amid-stock-price-decline-3648982",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MannKindCorp_technicaldot_3648982.png",
"date": "2025-10-27 15:40:55",
"description": "MannKind Corp., a small-cap pharmaceutical company, has seen significant stock price fluctuations, currently at $5.31. Despite a challenging year-to-date performance compared to the S&P 500, the company has demonstrated resilience with a notable 5-year return. Technical indicators reflect mixed sentiments, underscoring the need for ongoing evaluation."
},
{
"title": "MannKind Corp. Forms Golden Cross, Signaling Potential Bullish Breakout",
"link": "https://www.marketsmojo.com/news/stocks-in-action/mannkind-corp-forms-golden-cross-signaling-potential-bullish-breakout-3626530",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MannKindCorp_goldencross_3626530.png",
"date": "2025-10-16 17:10:10",
"description": "MannKind Corp. has recently achieved a Golden Cross, indicating a potential shift in momentum. Despite a challenging year with a 20.88% decline, the stock has shown resilience, rising today while the S&P 500 dipped. Long-term performance remains strong, with notable gains over three and five years."
},
{
"title": "MannKind Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics",
"link": "https://www.marketsmojo.com/news/stocks-in-action/mannkind-corp-technical-trend-shifts-from-mildly-bearish-to-sideways-amid-stock-fluctuations-3601091",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MannKindCorp_technicaldot_3601091.png",
"date": "2025-10-07 20:00:10",
"description": "MannKind Corp., a small-cap pharmaceutical company, has seen its stock price slightly decrease to $5.66, following notable volatility over the past year. Despite a recent weekly return of 5.01%, the year-to-date performance reflects an 11.98% decline, contrasting with broader market trends. The company has demonstrated significant resilience over five years."
},
{
"title": "Is MannKind Corp. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-mannkind-corp-technically-bullish-or-bearish-3599027",
"imagepath": "",
"date": "2025-10-07 12:16:30",
"description": "As of 3 October 2025, the technical trend for MannKind Corp. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators influencing this position. The weekly MACD is bullish, while the monthly MACD is mildly bearish. Bollinger Bands indicate a mildly bullish stance on the weekly and bullish on the monthly. However, daily moving averages are mildly bearish, and both the KST and Dow Theory show mixed signals with no clear trend. \n\nIn terms of performance, MannKind has underperformed against the S&P 500 year-to-date and over the past year, with returns of -11.98% and -12.79%, respectively, compared to the S&P 500's 14.18% and 17.82%. Over longer periods, the stock has performed better, with a 5-year return of 216.20% versus the S&P 500's 100.56%...."
},
{
"title": "Is MannKind Corp. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-mannkind-corp-technically-bullish-or-bearish-3593753",
"imagepath": "",
"date": "2025-10-06 12:06:34",
"description": "As of 3 October 2025, the technical trend for MannKind Corp. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across various indicators. The weekly MACD and Bollinger Bands are bullish, while the monthly MACD and moving averages are mildly bearish. The KST shows a bullish signal weekly but is mildly bearish monthly. The Dow Theory indicates a mildly bullish trend on the weekly timeframe, while there is no trend on the monthly. \n\nIn terms of performance, MannKind has outperformed the S&P 500 over the past week and month, with returns of 4.16% and 4.54% respectively, but has underperformed year-to-date and over the past year. Overall, the mixed signals suggest a cautious approach...."
},
{
"title": "Is MannKind Corp. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-mannkind-corp-technically-bullish-or-bearish-3591827",
"imagepath": "",
"date": "2025-10-05 11:51:32",
"description": "As of 3 October 2025, the technical trend for MannKind Corp. has changed from mildly bearish to sideways. The current stance is neutral, with mixed indicators influencing the outlook. The weekly MACD is bullish, while the monthly MACD is mildly bearish. Bollinger Bands show bullish signals for both weekly and monthly periods. Daily moving averages indicate a mildly bearish trend. The KST is bullish on a weekly basis but mildly bearish monthly. Dow Theory suggests a mildly bullish stance weekly, with no trend monthly.\n\nIn terms of returns, MannKind has outperformed the S&P 500 over the past week and month, but it has underperformed significantly year-to-date and over the past year. The stock has shown strong performance over the 3-year and 5-year periods compared to the benchmark...."
},
{
"title": "Is MannKind Corp. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-mannkind-corp-technically-bullish-or-bearish-3546277",
"imagepath": "",
"date": "2025-09-20 19:28:26",
"description": "As of 8 September 2025, the technical trend for MannKind Corp. has changed from mildly bullish to sideways. The current stance is neutral, with mixed indicators influencing the outlook. The weekly MACD is bullish, while the monthly MACD is mildly bearish. Bollinger Bands are bullish for both weekly and monthly periods. Moving averages indicate a mildly bearish trend on a daily basis. Dow Theory shows a mildly bullish stance for both weekly and monthly periods. \n\nIn terms of performance, MannKind has outperformed the S&P 500 over the past week and month, with returns of 3.51% and 47.24%, respectively, compared to the S&P 500's 1.05% and 2.33%. However, the longer-term returns are negative, with a year-to-date return of -12.75% versus the S&P 500's 12.22%, and a one-year return of -15.77% compared to 17.14% for the index...."
},
{
"title": "Is MannKind Corp. overvalued or undervalued?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-mannkind-corp-overvalued-or-undervalued-3542877",
"imagepath": "",
"date": "2025-09-20 18:04:30",
"description": "As of 9 November 2016, MannKind Corp. moved from does not qualify to risky. The company is currently overvalued based on its valuation metrics. Key ratios include a P/E ratio of 26, an EV to EBITDA of 13.61, and a PEG ratio of 0.06, which suggests a significant discrepancy in growth expectations relative to its price. \n\nIn comparison to peers, MannKind Corp. has a P/E ratio of 38.35, which is notably higher than Catalyst Pharmaceuticals, Inc. at 12.14, indicating that MannKind may be overvalued despite its risky classification. Additionally, while MannKind's 5-year return of 169.71% outperformed the S&P 500's 96.61%, its year-to-date return of -12.75% underperformed against the S&P 500's 12.22%, reinforcing the notion of overvaluation in the current market context...."
}
],
"total": 14,
"sid": "1157257",
"stock_news_url": "https://www.marketsmojo.com/news/mannkind-corp-1157257"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}

News and Views

MannKind Corp. Hits Day High with Strong 10.58% Intraday Surge

2025-11-06 16:14:10

MannKind Corp. has seen a notable increase in its stock performance today, reaching an intraday high amid broader market trends. Despite recent gains, the company faces long-term challenges, including a decline in one-year performance and negative financial indicators, highlighting a complex market position.

MannKind Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-10-27 15:40:55

MannKind Corp., a small-cap pharmaceutical company, has seen significant stock price fluctuations, currently at $5.31. Despite a challenging year-to-date performance compared to the S&P 500, the company has demonstrated resilience with a notable 5-year return. Technical indicators reflect mixed sentiments, underscoring the need for ongoing evaluation.

MannKind Corp. Forms Golden Cross, Signaling Potential Bullish Breakout

2025-10-16 17:10:10

MannKind Corp. has recently achieved a Golden Cross, indicating a potential shift in momentum. Despite a challenging year with a 20.88% decline, the stock has shown resilience, rising today while the S&P 500 dipped. Long-term performance remains strong, with notable gains over three and five years.

MannKind Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-10-07 20:00:10

MannKind Corp., a small-cap pharmaceutical company, has seen its stock price slightly decrease to $5.66, following notable volatility over the past year. Despite a recent weekly return of 5.01%, the year-to-date performance reflects an 11.98% decline, contrasting with broader market trends. The company has demonstrated significant resilience over five years.

Is MannKind Corp. technically bullish or bearish?

2025-10-07 12:16:30

As of 3 October 2025, the technical trend for MannKind Corp. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators influencing this position. The weekly MACD is bullish, while the monthly MACD is mildly bearish. Bollinger Bands indicate a mildly bullish stance on the weekly and bullish on the monthly. However, daily moving averages are mildly bearish, and both the KST and Dow Theory show mixed signals with no clear trend. In terms of performance, MannKind has underperformed against the S&P 500 year-to-date and over the past year, with returns of -11.98% and -12.79%, respectively, compared to the S&P 500's 14.18% and 17.82%. Over longer periods, the stock has performed better, with a 5-year return of 216.20% versus the S&P 500's 100.56%....

Is MannKind Corp. technically bullish or bearish?

2025-10-06 12:06:34

As of 3 October 2025, the technical trend for MannKind Corp. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across various indicators. The weekly MACD and Bollinger Bands are bullish, while the monthly MACD and moving averages are mildly bearish. The KST shows a bullish signal weekly but is mildly bearish monthly. The Dow Theory indicates a mildly bullish trend on the weekly timeframe, while there is no trend on the monthly. In terms of performance, MannKind has outperformed the S&P 500 over the past week and month, with returns of 4.16% and 4.54% respectively, but has underperformed year-to-date and over the past year. Overall, the mixed signals suggest a cautious approach....

Is MannKind Corp. technically bullish or bearish?

2025-10-05 11:51:32

As of 3 October 2025, the technical trend for MannKind Corp. has changed from mildly bearish to sideways. The current stance is neutral, with mixed indicators influencing the outlook. The weekly MACD is bullish, while the monthly MACD is mildly bearish. Bollinger Bands show bullish signals for both weekly and monthly periods. Daily moving averages indicate a mildly bearish trend. The KST is bullish on a weekly basis but mildly bearish monthly. Dow Theory suggests a mildly bullish stance weekly, with no trend monthly. In terms of returns, MannKind has outperformed the S&P 500 over the past week and month, but it has underperformed significantly year-to-date and over the past year. The stock has shown strong performance over the 3-year and 5-year periods compared to the benchmark....

Is MannKind Corp. technically bullish or bearish?

2025-09-20 19:28:26

As of 8 September 2025, the technical trend for MannKind Corp. has changed from mildly bullish to sideways. The current stance is neutral, with mixed indicators influencing the outlook. The weekly MACD is bullish, while the monthly MACD is mildly bearish. Bollinger Bands are bullish for both weekly and monthly periods. Moving averages indicate a mildly bearish trend on a daily basis. Dow Theory shows a mildly bullish stance for both weekly and monthly periods. In terms of performance, MannKind has outperformed the S&P 500 over the past week and month, with returns of 3.51% and 47.24%, respectively, compared to the S&P 500's 1.05% and 2.33%. However, the longer-term returns are negative, with a year-to-date return of -12.75% versus the S&P 500's 12.22%, and a one-year return of -15.77% compared to 17.14% for the index....

Is MannKind Corp. overvalued or undervalued?

2025-09-20 18:04:30

As of 9 November 2016, MannKind Corp. moved from does not qualify to risky. The company is currently overvalued based on its valuation metrics. Key ratios include a P/E ratio of 26, an EV to EBITDA of 13.61, and a PEG ratio of 0.06, which suggests a significant discrepancy in growth expectations relative to its price. In comparison to peers, MannKind Corp. has a P/E ratio of 38.35, which is notably higher than Catalyst Pharmaceuticals, Inc. at 12.14, indicating that MannKind may be overvalued despite its risky classification. Additionally, while MannKind's 5-year return of 169.71% outperformed the S&P 500's 96.61%, its year-to-date return of -12.75% underperformed against the S&P 500's 12.22%, reinforcing the notion of overvaluation in the current market context....

View All News